Loading clinical trials...
Loading clinical trials...
A Phase 1, Multicenter, Open-label Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of hSTC810 Monotherapy in Subjects With Advanced Solid Tumors
Conditions
Interventions
hSTC810
Locations
5
United States
Yale Cancer Center
New Haven, Connecticut, United States
Mount Sinai Hospital
New York, New York, United States
MD Anderson Cancer Center
Houston, Texas, United States
Korea University Anam Hospital
Seoul, South Korea
Yonsei University Severance Hospital
Seoul, South Korea
Start Date
April 18, 2022
Primary Completion Date
February 29, 2024
Completion Date
February 29, 2024
Last Updated
March 13, 2024
NCT05720117
NCT06898450
NCT05719558
NCT05098132
NCT07477743
NCT06598800
Lead Sponsor
STCube, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions